Oakworth Capital, Inc. Edwards Lifesciences Corp Transaction History
Oakworth Capital, Inc.
- $1.45 Billion
- Q4 2024
A detailed history of Oakworth Capital, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Oakworth Capital, Inc. holds 3,500 shares of EW stock, worth $248,815. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,500
Previous 3,500
-0.0%
Holding current value
$248,815
Previous $230,000
12.61%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding EW
# of Institutions
1,383Shares Held
453MCall Options Held
6.71MPut Options Held
3.17M-
Vanguard Group Inc Valley Forge, PA69.1MShares$4.91 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.62 Billion0.11% of portfolio
-
State Street Corp Boston, MA25.8MShares$1.83 Billion0.08% of portfolio
-
Jpmorgan Chase & CO New York, NY14.9MShares$1.06 Billion0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA13.6MShares$970 Million0.08% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $44B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...